سعر تيكليفا 0.004% قطرة للعين 2.5مل 2025

Travoprost 0.004% eye drops, 2.5 ml bottle (EVA Pharma, Egypt), antiglaucoma prostaglandin analogue.

• Decrease of elevated IOP in adults with ocular hypertension or open-angle glaucoma; and in paediatric patients aged 2 months to <18 years with ocular hypertension or paediatric glaucoma.Population: Adults and paediatric patients 2 months to <18 yearsEuropean Medicines Agency (EMA)
• Reduction of elevated IOP in open-angle glaucoma or ocular hypertension.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common in clinical trials: ocular hyperaemia (about 20%) and iris hyperpigmentation (about 6%).International label, same formulation · European Medicines Agency (EMA)

• Hypersensitivity to the active substance or any excipient.International label, same formulation · European Medicines Agency (EMA)

• May gradually and permanently change eye colour (increased melanosomes in iris melanocytes); unilateral treatment can cause permanent heterochromia; patients must be informed before treatment.International label, same formulation · European Medicines Agency (EMA)

• Travoprost has harmful pharmacological effects on pregnancy and/or the fetus/newborn; should not be used during pregnancy unless clearly necessary.International label, same formulation · European Medicines Agency (EMA)
• Unknown whether excreted in human milk (animal milk excretion shown); use by breast-feeding mothers is not recommended.International label, same formulation · European Medicines Agency (EMA)

• Travoprost: Prostaglandin F2-alpha analogue / FP receptor agonist that lowers intraocular pressure (directory pharmacology summary).